secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001326190-26-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune raises ~$75M in registered direct offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Issued 12.4M shares and pre-funded warrants for 4.6M shares at $4.40/share; gross proceeds ~$75M.
- Closing expected Jan 29, 2026; Titan Partners acted as sole placement agent.
- Pre-funded warrants exercisable at $0.001, no expiration, 9.99% beneficial ownership limit.
- Directors and officers subject to 30-day lock-up agreements with customary exceptions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619026000006/0001326190-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619026000006/alt-20260127x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer